Table 1 Clinicopathological characteristics of patients with thymoma. Tumor stages are defined by Masaoka-Koga classification
From: Using proteomic profiling to characterize protein signatures of different thymoma subtypes
Factors | Number (%) |
|---|---|
Age | |
≧60 | 6 (28.6) |
< 60 | 15 (71.4) |
Gender | |
Male | 10 (47.6) |
Female | 11 (52.4) |
Stage | |
I | 9 (42.9) |
II | 7 (33.3) |
III | 2 (9.5) |
IV | 3 (14.3) |
WHO classification | |
AB | 8 (38.1) |
B2 | 8 (38.1) |
B3 | 5 (23.8) |